These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16615425)

  • 21. [Tuberculosis in an FDG PET-TC study in a patient with suspected tumour recurrence of a pulmonary neoplasm].
    Pifarré P; Cortés M; Madroñal N; Fernández A; Caresia P; Gámez C
    Rev Esp Med Nucl; 2008; 27(6):440-1. PubMed ID: 19094904
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
    Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour thrombus from follicular thyroid cancer detected by 18F-FDG-PET/CT.
    Ozülker T; Ozülker F; Eker O; Ozpaçaci T; Ozcan D
    Hell J Nucl Med; 2009; 12(1):66-7. PubMed ID: 19330189
    [No Abstract]   [Full Text] [Related]  

  • 24. Preoperative evaluation of patients with squamous cell carcinoma of the oral cavity: fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography and ultrasonography versus histopathology.
    Sugawara C; Takahashi A; Kubo M; Otsuka H; Ishimaru N; Miyamoto Y; Honda E
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):516-25. PubMed ID: 22986248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity.
    Pasha MA; Marcus C; Fakhry C; Kang H; Kiess AP; Subramaniam RM
    AJR Am J Roentgenol; 2015 Aug; 205(2):W150-61. PubMed ID: 26001119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
    Kim SY; Roh JL; Kim JS; Ryu CH; Lee JH; Cho KJ; Choi SH; Nam SY
    Eur J Surg Oncol; 2008 Feb; 34(2):208-15. PubMed ID: 17482789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus.
    Hara T; Truelove J; Tawakol A; Wojtkiewicz GR; Hucker WJ; MacNabb MH; Brownell AL; Jokivarsi K; Kessinger CW; Jaff MR; Henke PK; Weissleder R; Jaffer FA
    Circulation; 2014 Sep; 130(13):1044-52. PubMed ID: 25070665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG PET/CT in the management of nasopharyngeal carcinoma.
    Mohandas A; Marcus C; Kang H; Truong MT; Subramaniam RM
    AJR Am J Roentgenol; 2014 Aug; 203(2):W146-57. PubMed ID: 25055290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma.
    Cetina L; Serrano A; Cantú-de-León D; Pérez-Montiel D; Estrada E; Coronel J; Hernández-Lucio M; Dueñas-González A
    Rev Invest Clin; 2011; 63(3):227-35. PubMed ID: 21888286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of FDG PET/CT in staging of oral cancer: four simultaneous primary malignancies.
    Linz C; Müller-Richter UD; Kircher S; Lapa C; Bluemel C
    Clin Nucl Med; 2015 May; 40(5):455-7. PubMed ID: 25742223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma.
    Pentenero M; Cistaro A; Brusa M; Ferraris MM; Pezzuto C; Carnino R; Colombini E; Valentini MC; Giovanella L; Spriano G; Gandolfo S
    Head Neck; 2008 Nov; 30(11):1488-96. PubMed ID: 18767178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
    J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
    Lee HS; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
    Eur J Radiol; 2014 Aug; 83(8):1455-60. PubMed ID: 24929443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
    Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
    Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.
    Kunkel M; Förster GJ; Reichert TE; Jeong JH; Benz P; Bartenstein P; Wagner W; Whiteside TL
    Cancer; 2003 Nov; 98(10):2257-65. PubMed ID: 14601097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
    Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxic volume evaluated by
    Sato J; Kitagawa Y; Watanabe S; Asaka T; Ohga N; Hirata K; Shiga T; Satoh A; Tamaki N
    Int J Oral Maxillofac Surg; 2018 May; 47(5):553-560. PubMed ID: 29030021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis.
    Hu S; Zhang J; Cheng C; Liu Q; Sun G; Zuo C
    Abdom Imaging; 2014 Dec; 39(6):1221-7. PubMed ID: 24913670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
    Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
    J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.